NCT05865015

Brief Summary

Infertility affects around 15 % of couples in their reproductive years. Even though the use of assisted reproductive technologies (ART) in aforementioned couples is increasing, their success rate is still relatively low. Hence it is important to identify and better understand potential modifiable dietary and lifestyle risk factors that may influence the success of ART. This study will include women undergoing IVF with a view to investigating the relationship between preconception dietary patterns, body composition, physical activity level, serum values of vitamin B9, vitamin B12 and vitamin D and the outcomes of IVF, such as the number of obtained oocytes, fertilization rate and clinical pregnancy. Main hypothesis is that women undergoing IVF, who eat a balanced diet, maintain healthy body weight and have adequate serum levels of vitamin B9, vitamin B12 and vitamin D, have a higher chance of achieving better IVF outcomes.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
69

participants targeted

Target at P25-P50 for all trials

Timeline
Completed

Started Jan 2023

Shorter than P25 for all trials

Geographic Reach
1 country

2 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 5, 2023

Completed
2 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 2, 2023

Completed
2 months until next milestone

First Submitted

Initial submission to the registry

May 9, 2023

Completed
9 days until next milestone

First Posted

Study publicly available on registry

May 18, 2023

Completed
4 months until next milestone

Study Completion

Last participant's last visit for all outcomes

September 10, 2023

Completed
Last Updated

May 9, 2024

Status Verified

February 1, 2024

Enrollment Period

2 months

First QC Date

May 9, 2023

Last Update Submit

May 7, 2024

Conditions

Keywords

Dietary PatternsMediterranean dietIn Vitro FertilizationDietFertilityInfertilityAssisted Reproduction

Outcome Measures

Primary Outcomes (1)

  • Oocyte number

    Total Number of oocytes produced.

    3 months

Secondary Outcomes (1)

  • Fertilization rate

    3 months

Other Outcomes (1)

  • Clinical pregnancy rate

    6 months

Eligibility Criteria

Age20 Years - 39 Years
Sexfemale
Healthy VolunteersYes
Age GroupsAdult (18-64)
Sampling MethodNon-Probability Sample
Study Population

Women undergoing IVF treatment at the University Medical Centre Ljubljana.

You may qualify if:

  • Undergoing IVF/ICSI treatment

You may not qualify if:

  • Women's age \> 39
  • Endometriosis

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

Division of Ob/Gyn, University Medical Centre Ljubljana

Ljubljana, 1000, Slovenia

Location

Division of Peadiatrics, University Medical Centre Ljubljana

Ljubljana, 1000, Slovenia

Location

Biospecimen

Retention: SAMPLES WITHOUT DNA

The patient will have blood drawn for biochemical laboratory tests at the Clinical Institute of Clinical Chemistry and Biochemistry, University Clinical Centre Ljubljana (in addition to the standard tests, the investigators will also determine vitamin B9 or folate and folic acid, vitamin B12, vitamin D, oligoelements, heavy metals, hormone disruptors, etc.) The protection of personal data will be guaranteed, as each blood sample will be labelled or recorded during the study under a code identical to the code of the questionnaire completed by the patient. Information on the results of the IVF/ICSI procedure will be obtained from the patients' medical records with their consent.

MeSH Terms

Conditions

Body WeightInfertility

Condition Hierarchy (Ancestors)

Signs and SymptomsPathological Conditions, Signs and SymptomsGenital DiseasesUrogenital Diseases

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
CROSS SECTIONAL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

May 9, 2023

First Posted

May 18, 2023

Study Start

January 5, 2023

Primary Completion

March 2, 2023

Study Completion

September 10, 2023

Last Updated

May 9, 2024

Record last verified: 2024-02

Locations